BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: López-Campos F, González-San Segundo C, Conde-Moreno AJ, Couñago F. Metastatic hormone-sensitive prostate cancer: How should it be treated? World J Clin Oncol 2021; 12(2): 43-49 [PMID: 33680871 DOI: 10.5306/wjco.v12.i2.43]
URL: https://www.wjgnet.com/2218-4333/full/v12/i2/43.htm
Number Citing Articles
1
A. B. Reiss, U. Saeedullah, D. J. Grossfeld, A. D. Glass, A. Pinkhasov, A. E. Katz. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive functionClinical and Translational Oncology 2021; 24(5): 733 doi: 10.1007/s12094-021-02727-1
2
Xingyu Xiong, Shi Qiu, Xianyanling Yi, Hang Xu, Haoran Lei, Dazhou Liao, Shengjiang Bai, Ge Peng, Qiang Wei, Jianzhong Ai, Lu Yang. Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systematic reviewUrologic Oncology: Seminars and Original Investigations 2022; 40(1): 4.e19 doi: 10.1016/j.urolonc.2021.08.014